ASKA Pharmaceutical Holdings Co.,Ltd.
Research ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) on Bullrun: market cap JPY 57.98B, P/E 12.7, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4886.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 57.98B
- P/E12.7
- Dividend yield3.2%
- Financial periodFY2026
- RevenueJPY 71.13B
- Revenue growth10.9%
- Net incomeJPY 5.42B
- Free cash flowJPY 3.43B
- Gross margin48.0%
Valuation Snapshot
latest market cap is JPY 57.98B; P/E is 12.7; dividend yield is 3.2%.
Peer valuation comparison
Latest P/E is 12.73x versus a Healthcare sector median of 21.69x (41.3% below).
Latest dividend yield is 3.24% versus a Healthcare sector median of 2.41% (34.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 71.13B | JPY 5.42B | JPY 3.43B | 48.0% | 191.12 | JPY 10.13B | JPY 11.43B | JPY 70.36B |
| FY2025 | JPY 64.14B | JPY 5.10B | -JPY 1.08B | 48.9% | 179.95 | JPY 10.60B | JPY 10.90B | JPY 65.31B |
| FY2024 | JPY 62.84B | JPY 7.55B | JPY 33.00M | 48.8% | 266.51 | JPY 13.74B | JPY 9.49B | JPY 61.93B |
| FY2023 | JPY 60.46B | JPY 4.24B | JPY 2.61B | 47.3% | 150.08 | JPY 14.51B | JPY 12.62B | JPY 54.53B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 57.98B | 12.7 | 3.2% | 66 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 66 JPY, yield 3.2%.
| Year | Dividends/share |
|---|---|
| FY2026 | 65 JPY |
| FY2025 | 57 JPY |
| FY2024 | 45 JPY |
| FY2023 | 28 JPY |
About ASKA Pharmaceutical Holdings Co.,Ltd.
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ASKA Pharmaceutical Holdings Co.,Ltd.'s market cap?
ASKA Pharmaceutical Holdings Co.,Ltd.'s market capitalization is JPY 57.98B.
What is ASKA Pharmaceutical Holdings Co.,Ltd.'s P/E ratio?
ASKA Pharmaceutical Holdings Co.,Ltd.'s price-to-earnings (P/E) ratio is 12.7.
Does ASKA Pharmaceutical Holdings Co.,Ltd. pay a dividend?
ASKA Pharmaceutical Holdings Co.,Ltd. has a dividend yield of 3.2%.
What does ASKA Pharmaceutical Holdings Co.,Ltd. do?
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology; and research, manufactures, imports, exports, and sells veterinary medicines and medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials.